Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open-label Controlled Trial of Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on Anti-retroviral Therapy in Malawi

NCT01650558 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT01650558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01650558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open-label Controlled Trial of Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on Anti-retroviral Therapy in Malawi
Lead sponsor
University of Maryland, Baltimore
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2012
Completion date
July 31, 2018
Enrollment
1,499 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv